glp 1 agonist parkinson Use of Glucagon-Like Peptide-1 Are GLP-1 diabetes drugs like
Description
Victoza, a GLP-1 drug released in 2010, had side effects discovered about it, eventually resulting in official warning from the FDA in 2013
In a 48-week, placebo-controlled phase-2 trial (338 participants) reported by Lilly, the highest dose achieved a mean weight reduction of 24.2% (about 57.8 lb) at the end of treatment
& Jenkins, A
Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity
Traussnigg, S
Gastric Distension Induces C-Fos in Medullary GLP-1/2-Containing Neurons. American Journal of Physiology
